January 2026 in “Journal of Ayurveda and Naturopathy” This review highlights that Eclipta alba, or false daisy, shows promise for liver protection and hair care due to its antioxidant and tissue-protective properties, supporting its traditional Ayurvedic uses for treating liver disorders and promoting hair growth.
November 2025 in “The Bioscan.” This case report describes a 30-year-old man with alopecia areata who experienced recovery following treatment with the homeopathic medication Pix Liquida.
September 2025 in “International Journal of Advanced Academic Studies” This review examines Ayurvedic and modern literature on combining Anu Taila Nasya and Gokshura lepa for hair loss and presents no new clinical results.
August 2025 in “International Journal of Research in Ayurveda and Pharmacy” In this case study, a 35-year-old woman with persistent hair loss saw noticeable improvements after five weeks of Jalaukavacharana (Leech Therapy) and supportive Ayurvedic treatment, suggesting potential benefits of this approach for hair loss conditions.
July 2025 in “International Journal of Homoeopathic Sciences” This study suggests that homeopathic treatments may significantly improve menstrual regularity, reduce cystic formations, and enhance the overall quality of life for women with polycystic ovarian disease, indicating its potential as a complementary therapy in gynecological care.
April 2025 in “International Journal of Homoeopathic Sciences” This case report describes marked improvement in symptoms for a 24-year-old woman with PCOS following individualized homeopathic treatment, which reportedly included a reduction in irregular menstruation, vaginal discomfort, and weight gain.
January 2025 in “International Journal of Advanced Biochemistry Research” This research proposes to investigate the incidence of skin diseases in dogs from North-eastern India linked to deficiencies in alpha-linolenic and linoleic acids, as these essential fatty acids have anti-inflammatory and immunomodulatory benefits potentially aiding inflammatory skin disease therapy.
January 2025 in “International journal of Indian medicine” This review discusses nine Ayurvedic medicinal herbs listed in the Dhanvantari Nighantu as beneficial for hair, detailing their properties like promoting hair growth, enhancing hair thickness, and maintaining dark hair color, alongside supporting research on these effects.
September 2024 in “Indian Journal of Skin Allergy” This review article explores the current use and evidence of stem cell therapy in dermatology, detailing its applications, benefits, and limitations across various skin disorders, while also addressing teledermatology's rise during COVID-19 and proposing its ongoing integration into healthcare delivery.
June 2024 in “International Journal of Ayurveda and Pharma Research” In this study involving 40 PCOS patients, the authors observed notable improvements in menstrual cycle regularity and ovarian cyst volume reduction using Tila kashayam and Shatapuspa choornam treatments, though they reported no significant changes in hirsutism, BMI, or waist circumference over three months.
February 2024 in “Journal of ayurveda and integrated medical sciences” This paper reviews Ayurvedic concepts related to PCOS and compares them with PCOS symptoms, without presenting new clinical findings.
January 2024 in “Sanjeevani Darshan National Journal of Ayurveda & Yoga” This study aims to evaluate the efficacy of a treatment approach called Sthanika Chikitsa, involving Shiro Lepa and specific herbal and nasal preparations, for managing Indralupta, a condition akin to Alopecia Areata characterized by hair loss. Results are not provided in the abstract.
September 2023 in “Kerala Journal of Ayurveda” In this case report, a 24-year-old woman with PCOS-related symptoms improved her menstrual regularity and reduced symptoms like mood swings and facial hair growth through Ayurvedic treatments, highlighting their potential role in managing secondary amenorrhea without adverse effects.
August 2023 in “International journal of research in Ayurveda and pharmacy” This review discusses the potential role of Garudan kizhangu ennai, a polyherbal Siddha formulation, in managing alopecia areata and highlights its various pharmacological properties, although further clinical studies are needed to confirm its efficacy.
January 2023 in “Indian Journal of Unani Medicine” This report suggests that a Unani formulation, jawarish Falafali, effectively reduced symptoms and TSH levels in a 35-year-old woman with hypothyroidism over two months, while T3 and T4 levels remained normal.
December 2022 in “The Indian journal of chest diseases & allied sciences” This study found that sleep disorders, especially poor sleep quality, are common in women with PCOS, suggesting the need for regular screening using specific questionnaires.
July 2021 in “Journal of emerging technologies and innovative research” This article discusses Ayurvedic perspectives on acne vulgaris and outlines potential natural remedies, but it presents no new clinical findings.
March 2021 in “Clin-Alert” This abstract lists a range of drugs and treatment agents like Abatacept, Amiodarone, and Remdesivir, but does not report any study results or findings.
July 2018 in “International journal of research - granthaalayah” In this clinical trial, the authors observed that Dravanti beeja lepa may be safe and effective for promoting hair regrowth in patients with Indralupta (Alopecia Areata).
August 2017 in “International journal of Ayurvedic and herbal medicine” This review discusses the Ayurvedic perspectives on Bhallataka, noting its detoxified forms may have various therapeutic properties, but reports no new clinical findings.
January 2014 in “International Journal of Case Reports and Images” This case report describes a 62-year-old woman diagnosed with undifferentiated connective tissue disease and renal amyloidosis, presenting symptoms like joint pain, Raynaud's phenomenon, and carpal tunnel syndrome.
March 2002 in “Clin-Alert” In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.
18 citations
,
October 2015 in “Journal of the European Academy of Dermatology and Venereology” This assessment of European Dermatology Forum guidelines found varying methodological quality, with S3 guidelines scoring highest overall, highlighting a need for standardization in guideline development.
3 citations
,
August 2023 in “Drug safety” This source reports that trastuzumab deruxtecan improves outcomes in HER2-positive and HER2-low metastatic breast cancer, emphasizing the need for careful adverse event monitoring, particularly for interstitial lung disease, and managing emetic risk to maximize benefits.
2 citations
,
December 2023 in “Health Technology Assessment” In this study, researchers found that in the UK, laser treatment for hidradenitis suppurativa had the highest participant eligibility and preference compared to other interventions, highlighting its potential priority in future trials.
213 citations
,
June 2017 in “Rheumatology” This guideline outlines the management of systemic lupus erythematosus in adults but reports no new clinical findings.
39 citations
,
October 2018 in “Lupus Science & Medicine” This article discusses various patterns of hair loss associated with lupus erythematosus, emphasizing the importance of identifying the specific type to aid in classifying systemic lupus erythematosus.
37 citations
,
January 2016 in “Drug design, development and therapy” This review discusses the use of tofacitinib as a treatment for plaque psoriasis, highlighting its efficacy and safety in clinical trials, but notes unresolved questions regarding long-term safety.
17 citations
,
August 2019 in “Frontiers in Immunology” This review examines non-invasive methods for diagnosing inflammatory skin diseases like lupus erythematosus and psoriatic inflammation using samples from plucked hair and skin tape-strips, but no new clinical results are presented.
17 citations
,
July 2017 in “International Journal of Behavioral Medicine” This study validated the Egyptian Arabic version of the Skindex-16 and found that skin conditions significantly impacted patients' quality of life, particularly in the emotional domain.